Close

EBV LMP1

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

EBV is the causative agent of infectious mononucleosis and is associated with several human lymphoid and epithelial malignancies including Burkitt's lymphoma, nasopharyngeal carcinoma (NPC), T-cell lymphoma and Hodgkin's disease. EBV LMP-1, Epstein-Barr virus latent membrane protein 1,is an virus(EBV) protein that regulates its own expression and the expression of human genes. LMP1 is the best-documented oncoprotein of the EBV latent gene products, as it is expressed in most EBV-related human cancers. LMP1 can stimulate or inhibit signaling pathways, resulting in transformation of rodent fibroblast cell lines, blockade of differentiation in epithelial cells, upregulation of anti-apoptotic proteins, production of cytokines, upregulation of cell surface markers, upregulation of DNA methyltransferase activity, and downregulation of cell adhesion molecules and cyclin-dependent kinases.

Associated Disease
  • CAR Vector Products

  • CAR Viral Particles

Loading...
  • Target Species:
  • Antibody Clone:
  • Antibody Host:
  • Receptor Construction:
  • Vector Type:
  • Targeting Cell Type:
CAT Product Name Target Species Antibody Clone Antibody Host Receptor Construction Vector Type Targeting Cell Type CAR Vector Type Inquiry & Datasheet
CAR-LC156 Anti-EBV LMP1 h(CD28-41BB-CD3ζ) CAR, pCDCAR1 Human Human scFv-CD28-41BB-CD3ζ Retroviral T cell   Add to Cart   Datasheet
XS-1022-ZP225 Anti-EBV LMP1 (A4) h(41BB-CD3ζ) CAR, pCDCAR1 Human A4 Human scFv-41BB-CD41ζ Lentiviral vector T cell   Add to Cart   Datasheet
XS-1022-ZP226 Anti-EBV LMP1 (A4) h(CD28-CD3ζ) CAR, pCDCAR1 Human A4 Human scFv-CD28-CD41ζ Lentiviral vector T cell   Add to Cart   Datasheet
XS-1022-ZP227 Anti-EBV LMP1 (E2) h(41BB-CD3ζ) CAR, pCDCAR1 Human E2 Human scFv-41BB-CD40ζ Lentiviral vector T cell   Add to Cart   Datasheet
XS-1022-ZP228 Anti-EBV LMP1 (E2) h(CD28-CD3ζ) CAR, pCDCAR1 Human E2 Human scFv-CD28-CD40ζ Lentiviral vector T cell   Add to Cart   Datasheet
XS-1022-ZP233 Anti-EBV LMP1 (F5) h(41BB-CD3ζ) CAR, pCDCAR1 Human F5 Human scFv-41BB-CD41ζ Lentiviral vector T cell   Add to Cart   Datasheet
XS-1022-ZP234 Anti-EBV LMP1 (F5) h(CD28-CD3ζ) CAR, pCDCAR1 Human F5 Human scFv-CD28-CD41ζ Lentiviral vector T cell   Add to Cart   Datasheet
XS-1022-ZP235 Anti-EBV LMP1 (36) h(41BB-CD3ζ) CAR, pCDCAR1 Human 36 Human scFv-41BB-CD42ζ Lentiviral vector T cell   Add to Cart   Datasheet
XS-1022-ZP236 Anti-EBV LMP1 (36) h(CD28-CD3ζ) CAR, pCDCAR1 Human 36 Human scFv-CD28-CD42ζ Lentiviral vector T cell   Add to Cart   Datasheet
Unable to find the desired product? Explore the Filter Options at the top of the list.
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.